Insider Trading Activity Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) – CFO Sold 10,804 shares of Stock

ME Staff
-
0

Insider Trading Activity For Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)

Scott J Charles , CFO of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) reportedly Sold 10,804 shares of the company’s stock at an average price of 1.25 for a total transaction amount of $13,505.00 SEC Form

Insider Trading History For Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)

  • On 12/27/2012 John E Barnhardt, VP, sold 5,219 with an average share price of $5.25 per share and the total transaction amounting to $27,399.75.View SEC Filing
  • On 7/17/2013 Par Investment Partners Lp, Major Shareholder, bought 90,000 with an average share price of $5.25 per share and the total transaction amounting to $472,500.00.View SEC Filing
  • On 12/20/2013 John Fort, Insider, sold 22,500 with an average share price of $9.63 per share and the total transaction amounting to $216,675.00.View SEC Filing
  • On 4/24/2014 John Fort, Insider, sold 13,725 with an average share price of $9.61 per share and the total transaction amounting to $131,897.25.View SEC Filing
  • On 5/16/2014 William Hodges, CFO, sold 71,003 with an average share price of $8.16 per share and the total transaction amounting to $579,384.48.View SEC Filing
  • On 5/16/2014 John Fort, Insider, sold 4,000 with an average share price of $8.49 per share and the total transaction amounting to $33,960.00.View SEC Filing
  • On 5/22/2014 John Barnhardt, VP, sold 77,840 with an average share price of $8.31 per share and the total transaction amounting to $646,850.40.View SEC Filing

    • Analyst Ratings For Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)
    These are 3 Buy Ratings .
    The current consensus rating for Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) is Buy (Score: 3.00) with a consensus target price of $8.75 , a potential (600.00% upside)

    Analyst Ratings History For Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)

    • On 3/16/2016 Dundee Securities Lower Price Target of rating Buy with a price target of $10.00 to $9.00
    • On 10/10/2016 Guggenheim Set Price Target of rating Buy with a price target of $12.00
    • On 3/15/2017 Chardan Capital Lower Price Target of rating Buy to Buy with a price target of $10.00 to $5.50
    • On 4/10/2017 Bloom Burton Upgraded rating Accumulate to Buy

    Dividend History For Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)

  • On 11/21/2013 Aralez Pharmaceuticals Inc. announced a special dividend of $1.75 with an ex dividend date of 12/31/2013 which will be payable on 12/30/2013.

    • Recent Trading Activity for Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)
    Shares of Aralez Pharmaceuticals Inc. closed the previous trading session at 1.25 up +0.01 0.81% with 548,809 shares trading hands.